SCHEMBL19680541

SCHEMBL19680541

Cc1cc(O)nc2c(C)cc(N)cc12

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 7/20 0.40
TSHR P16473 4/20 0.40
HTT P42858 3/20 0.40
LMNA P02545 3/20 0.40
GAA P10253 3/20 0.40
RAB9A P51151 2/20 0.40
MITF O75030 2/20 0.40
NPC1 O15118 1/20 0.40
TP53 P04637 1/20 0.40
AGTR1 P30556 1/20 0.40
SMN1; SMN2 Q16637 3/20 0.36
PDE10A Q9Y233 1/20 0.36
RPS6KA3 P51812 2/20 0.35
ALDH1A1 P00352 7/20 0.33
POLB P06746 2/20 0.33
RAD52 P43351 2/20 0.33
KMT2A Q03164 2/20 0.33
MAPT P10636 2/20 0.33
TDP1 Q9NUW8 1/20 0.33
BRD4 O60885 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8703414 0.84 THRB (0.41) KDM4ETSHRHTTLMNAGAA
SCHEMBL8703095 0.82 GAA (0.36) KDM4ETSHRHTTLMNAGAA
SCHEMBL11563302 0.80 KDM4E (0.52) KDM4ETSHRHTTLMNAGAA
SCHEMBL28843874 0.74 CCR1 (0.35) KDM4ETSHRHTTLMNAGAA
SCHEMBL5349570 0.72 TSHR (0.44) KDM4ETSHRHTTLMNAGAA
SCHEMBL29631413 0.71 KDM4E (0.51) KDM4EHTTLMNAGAARAB9A
SCHEMBL935117 0.71 KDM4E (0.51) KDM4EHTTLMNAGAARAB9A
SCHEMBL6231365 0.70 KDM4E (0.69) KDM4ETSHRHTTLMNAGAA
SCHEMBL17506375 0.68 MAPT (0.45) KDM4EHTTLMNARAB9AMITF
SCHEMBL4580511 0.68 MDM4 (0.44) KDM4ETSHRHTTLMNAGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10752640-B2 Compounds active towards bromodomains NUEVOLUTION A/S (DK) 2020-08-25 US disclosed
US-20170349607-A1 COMPOUNDS ACTIVE TOWARDS BROMODOMAINS NUEVOLUTION A/S (DK) 2017-12-07 US disclosed
US-20170349607-A1 COMPOUNDS ACTIVE TOWARDS BROMODOMAINS NUEVOLUTION A/S (DK) 2017-12-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170349607-A1 COMPOUNDS ACTIVE TOWARDS BROMODOMAINS BRD4, BRD3, BRDT KDM4E 626/4885TSHR 3378/4885HTT 1293/4885
US-10752640-B2 Compounds active towards bromodomains BRD4, BRD3, BRDT KDM4E 626/4885TSHR 3378/4885HTT 1293/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.